LINC00174 and cancer: However, the difference is that heterologous overexpression of LINC00174 also accelerated the migration and invasion ability of CRC cells, and may promote EMT protein and E2F7 by competitively binding miR-3127-5p to play a cancer-promoting role in CRC.